Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Helsen

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Endocrinology|September 24, 2013
Looking at nuclear receptors from a new angleChristine Helsen, Frank Claessens
Cellular and Molecular Life Sciences : CMLS|February 8, 2017
Comparing the rules of engagement of androgen and glucocorticoid receptorsFrank Claessens, Steven Joniau, Christine Helsen
Frontiers in Endocrinology|September 5, 2022
Editorial: Sexual dimorphism in biomedical research and its therapeutic implicationsJan Kroon, Shokoufeh Mahmoodzadeh, Christine Helsen
Molecular Endocrinology (Baltimore, Md.)|March 23, 2010
The rules of DNA recognition by the androgen receptorSarah Denayer, Christine Helsen, Lieven Thorrez, et al.
Chemmedchem|February 26, 2013
The discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedureArnout Voet, Christine Helsen, Kam Y J Zhang, et al.
Scientific Reports|September 23, 2021
Structure and stability of the designer protein WRAP-T and its permutantsBram Mylemans, Xiao Yin Lee, Ina Laier, et al.
Nuclear Receptor Signaling|July 10, 2008
Diverse roles of androgen receptor (AR) domains in AR-mediated signalingFrank Claessens, Sarah Denayer, Nora Van Tilborgh, et al.
International Journal of Molecular Sciences|February 15, 2022
The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2Christine Helsen, Tien Nguyen, Thomas Vercruysse, et al.
Molecular Cancer Therapeutics|April 13, 2012
Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growthChristine Helsen, Arnaud Marchand, Patrick Chaltin, et al.
Molecular Endocrinology (Baltimore, Md.)|October 11, 2013
Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementLiesbeth Clinckemalie, Lien Spans, Vanessa Dubois, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Endocrinology|September 24, 2013
Looking at nuclear receptors from a new angleChristine Helsen, Frank Claessens
Cellular and Molecular Life Sciences : CMLS|February 8, 2017
Comparing the rules of engagement of androgen and glucocorticoid receptorsFrank Claessens, Steven Joniau, Christine Helsen
Frontiers in Endocrinology|September 5, 2022
Editorial: Sexual dimorphism in biomedical research and its therapeutic implicationsJan Kroon, Shokoufeh Mahmoodzadeh, Christine Helsen
Molecular Endocrinology (Baltimore, Md.)|March 23, 2010
The rules of DNA recognition by the androgen receptorSarah Denayer, Christine Helsen, Lieven Thorrez, et al.
Chemmedchem|February 26, 2013
The discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedureArnout Voet, Christine Helsen, Kam Y J Zhang, et al.
Scientific Reports|September 23, 2021
Structure and stability of the designer protein WRAP-T and its permutantsBram Mylemans, Xiao Yin Lee, Ina Laier, et al.
Nuclear Receptor Signaling|July 10, 2008
Diverse roles of androgen receptor (AR) domains in AR-mediated signalingFrank Claessens, Sarah Denayer, Nora Van Tilborgh, et al.
International Journal of Molecular Sciences|February 15, 2022
The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2Christine Helsen, Tien Nguyen, Thomas Vercruysse, et al.
Molecular Cancer Therapeutics|April 13, 2012
Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growthChristine Helsen, Arnaud Marchand, Patrick Chaltin, et al.
Molecular Endocrinology (Baltimore, Md.)|October 11, 2013
Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementLiesbeth Clinckemalie, Lien Spans, Vanessa Dubois, et al.
Pageof 5